Metformin May Boost Cancer Survival, Curb Depression

Metformin

| Dec 16, 2012

Like aspirin, metformin is one of those drugs that over the years keeps proving itself beneficial in ways it wasn't originally intended to be.

Two recent studies show that metformin may boost the survival rate among ovarian cancer patients who have diabetes, as well as reduce the risk of depression, dementia, and Parkinson's disease in type 2 patients.

Researchers at the world-famous Mayo Clinic in Rochester, Minn., tracked 61 metformin-taking women with diabetes who also had ovarian cancer, and 178 diabetes-free ovarian cancer patients who were not taking the drug. Both groups were matched for age, stage of their cancer, and other factors.

Results showed that the metformin users had an improved survival rate. After five years, 67 percent of the women taking metformin had not died from the cancer, compared to 47 percent of the women without diabetes who did not use the drug.

Worldwide, several studies are now underway on metformin's cancer-fighting abilities. If scientists can establish as positive link between the drug's use and lessened risk of developing certain cancers, it could join the apothecary of anti-cancer drugs as a welcome low-cost therapy.

Developed in the 1950s and first marketed in the United States in the 1990s, metformin is cheap and easy to manufacture, and inexpensive to buy. Because it is the drug doctors and endocrinologists are most likely to prescribe as the starting therapy for newly diagnosed people with diabetes, it has a years-long track record of use by large numbers of patients with few adverse side effects.

Speculation about the reason for metformin's surprising cancer-fighting properties centers on the fact that metformin lowers the amount of insulin circulating in the blood. High amounts of insulin in the bloodstream are thought by some scientists to be a factor in the development of certain cancers.

An abstract of the study is available.

An Aid Against Depression?

In other welcome findings about metformin, Taiwanese researchers report that type 2s taking the drug were less likely to develop depression, as dementia and Parkinson's disease, especially if used with sulfonylureas. (The metformin/sulfonylurea combination is the most typical therapy doctors give type 2 patients.)

Diabetes is often associated with an increased risk of depression and other mood disorders, possibly because of negative effects on brain chemistry and structure. The researchers at Taiwan's National Health Research Institutes found that metformin users' risk of developing depression was more than 50 percent less than among type 2s who do not take the drug.

Diabetes is also linked to an increased risk of dementia and Parkinson's, both neurodegenerative
diseases.

An abstract of the 12-year study of Taiwanese adults with type 2 diabetes is available online in the medical journal BMC Medicine.

Click Here To View Or Post Comments

Categories: Diabetes, Diabetes Health, Diabetes Health Magazine, Diabetic, Metformin, Type 2


Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Latest
Popular
Top Rated
Print | Email | Share | Comments (0)

You May Also Be Interested In...


Comments


Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...


Username: Password:
Comment:
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.